What are the causes of hypophosphatemia with hyperphosphaturia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Hypophosphatemia with Hyperphosphaturia

Hypophosphatemia with hyperphosphaturia (renal phosphate wasting) is caused by either FGF23-mediated disorders or primary renal tubular defects, with the key discriminant being the FGF23 level. 1

Algorithmic Approach Based on FGF23 Levels

The diagnostic pathway hinges on measuring intact FGF23 levels in the setting of hypophosphatemia with documented renal phosphate wasting 1:

If FGF23 is NOT Suppressed (Normal or Elevated):

These are FGF23-mediated disorders where FGF23 inappropriately remains elevated despite hypophosphatemia:

Genetic Causes (80% is X-linked hypophosphatemia):

  • X-linked hypophosphatemia (XLH) - accounts for ~80% of cases with non-suppressed FGF23 1
  • Autosomal-dominant hypophosphatemic rickets
  • Autosomal-recessive hypophosphatemic rickets (types 1 and 2)
  • Raine syndrome
  • Hypophosphatemic rickets with hyperparathyroidism 1

Acquired Causes:

  • Tumor-induced osteomalacia - mesenchymal tumors secreting FGF23 1, 2
  • Intravenous iron therapy (ferric carboxymaltose or iron isomaltoside) - causes "6H-syndrome": high FGF23, hyperphosphaturia, hypophosphatemia, hypovitaminosis D, hypocalcemia, and secondary hyperparathyroidism 1, 3
  • Alcohol-induced FGF23 syndrome 1
  • Ectopic FGF23 syndrome - rare complication in advanced prostate or lung cancer 1
  • Fibrous dysplasia
  • Cutaneous skeletal hypophosphatemia syndrome/epidermal nevus syndrome
  • Osteoglophonic dysplasia
  • Neurofibromatosis type 1 1

If FGF23 IS Suppressed (Low or Low-Normal):

These are primary renal tubular defects where the kidney appropriately suppresses FGF23 in response to hypophosphatemia:

Fanconi Syndrome Variants (generalized proximal tubular dysfunction):

  • Cystinosis (prior to kidney failure)
  • Dent disease (types 1 and 2)
  • Hypophosphatemia with nephrocalcinosis
  • Reno-tubular syndrome type 2
  • Drug-induced (platinum-based chemotherapy, tyrosine kinase inhibitors) 4
  • Tacrolimus-induced tubular dysfunction 3

Isolated Renal Phosphate Wasting:

  • Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) - distinguished by hypercalciuria, unlike other causes 1
  • SLC34A1 or SLC34A3 mutations 2, 5

Secondary Causes:

  • Primary hyperparathyroidism (elevated PTH with high calcium)
  • Secondary hyperparathyroidism (elevated PTH with low calcium from vitamin D deficiency) 6
  • Renal tubular acidosis 3

Critical Diagnostic Workup

To establish the diagnosis, the 2025 guidelines recommend 1:

Blood tests:

  • Phosphate, calcium, creatinine, bicarbonate
  • 25(OH) vitamin D, 1,25(OH) vitamin D
  • PTH, alkaline phosphatase
  • Intact FGF23 (critical discriminant)

Urine tests:

  • Phosphate, calcium, creatinine (calculate TmP/GFR)
  • Amino acids, glucose, low-molecular-weight proteins (to exclude Fanconi syndrome)

Essential exclusions before diagnosing genetic causes 1:

  • Metabolic acidosis (measure bicarbonate)
  • Hypercalciuria (distinguishes HHRH from other causes)
  • Generalized Fanconi syndrome (aminoaciduria, glycosuria, proteinuria)

Common Pitfalls

  1. Failing to measure FGF23 - This is the single most important test to differentiate FGF23-mediated from primary tubular causes 1

  2. Missing iatrogenic causes - Always review recent medications, particularly IV iron (can cause delayed hypophosphatemia weeks after infusion) and denosumab 3

  3. Overlooking tumor-induced osteomalacia - Consider in adults with new-onset hypophosphatemia and non-suppressed FGF23, especially without family history 2

  4. Not excluding vitamin D deficiency and hyperparathyroidism - These common acquired causes must be ruled out first 1

  5. Assuming genetic testing is definitive - About one-third of XLH patients have no family history due to de novo mutations, and genetic testing may reveal variants of uncertain significance 2, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.